Sign in
4

Changes in Ownership

Organogenesis Holdings Inc. Filed Acc 0001062993-25-014296

Chief Commercial Officer gave up 2,173 shares (to pay taxes)

  • Chief Commercial Officer acquired 4,060 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Grow Brian Chief Commercial Officer 2025-08-11 Option exercise +4,060 $2.47 $10,028 674,550 D: show line 1 in the form
Grow Brian Chief Commercial Officer 2025-08-11 Shares withheld for taxes −2,173 $4.62 $10,028 672,377 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Grow Brian Chief Commercial Officer 2025-08-11 Option exercise · Stock Option (Right to Buy) −4,060 0 D: show line 3 in the form
Loading xslF345X05/form4.xml…